Ancient Grains Linked to Improved Type 2 Diabetes Outcomes

Health & Lifestyle
265

Translate to Spanish or other 102 languages!

A new study suggests ancient grains like oats and buckwheat may help manage blood sugar and cholesterol in type 2 diabetes. Image for illustration purposes
A new study suggests ancient grains like oats and buckwheat may help manage blood sugar and cholesterol in type 2 diabetes. Image for illustration purposes

Medical New Today

- Advertisement -
  • A new study suggests ancient grain consumption is associated with improved health outcomes for people with type 2 diabetes. 
  • Ancient grains like oats are rich in dietary fiber and phytochemicals that may help manage blood sugar and cholesterol. 
  • Experts recommend incorporating minimally refined grains into a healthy, balanced diet to reap the most benefits.

A new study highlights the potential benefits of including ancient grains in dietary patterns for people with diabetes.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/ancient-grains-may-help-treat-type-2-diabetes?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-05-06&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Some Action on a Pickleball Court Can be Fun & Safe, Even With a Heart Condition
Next article
Early Care and Education Providers – on the Frontlines of Public Health

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

Study: Menopause Hormone Therapy Declines Nationwide Despite Proven Benefits

Hormone therapy use among women in the U.S. remains low, even though it's an effective treatment for many menopause symptoms, according to a new Mayo Clinic study published in Mayo Clinic Proceedings.
- Advertisement -